The following discussion should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this annual report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include but are not limited to those discussed below and elsewhere in this Annual Report. Our audited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.





RESULTS OF OPERATIONS

As of January 31, 2020, we had total assets of $6,277 and total liabilities of $72,992. We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We expect we will require additional capital to meet our long-term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

We discontinued our cedar phyto barrels distribution business upon the change in control occurred on November 21, 2018 and started to implement a new business plan to pursue business opportunities in manufacturing and distribution of certain dietary ingredient and nutritional supplement products. As of January 31, 2020, and for the year then ended, we have not entered into any definitive agreement in connection with the business plan and generated only $6,000 revenue from consulting. Our net loss for the fiscal year ended January 31, 2020 was $53,771, as compared to a net loss of $44,831 during the fiscal year ended January 31, 2019.





                                   4  | Page

Year ended January 31, 2020 compared to the year ended January 31, 2019

Revenue, Cost of Revenue, and Gross Profit

During the year ended January 31, 2020, the Company generated $6,000 in consulting service revenue compared to $2,000 in consulting service revenue for the year ended January 31, 2019. There were no sales of any product in years ended January 31, 2020 and 2019.

The $6,000 revenue was generated in the three-months ended April 30, 2019 by providing consulting services to a third party for planning, design and compliance of cannabis cultivation in the USA. We have not been able to generate any other revenue for the rest of the year ended January 31, 2020.





Operating Expenses

During the year ended January 31, 2020, we incurred total general and administrative expenses of $58,971 which is an increase for $12,140 compared to $46,831 for the year ended January 31, 2019. General and administrative expenses incurred generally related to corporate overhead, financial and administrative contracted services, such as legal and accounting and various compliance costs.

Our net loss for the year ended January 31, 2020 was $53,771, compared to net loss of $44,831 for the year ended January 31, 2019. The increase in net loss in the year ended January 31, 2020 in the amount of $8,940 represents a 19.94% increase over the net loss in the previous year

LIQUIDITY AND CAPITAL RESOURCES

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs. This raises substantial doubt about its ability to continue as a going concern.

Our independent auditor's report accompanying our January 31, 2020 and 2019 audited financial statements contains an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. These financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business. This assumption may, however, not hold true for a variety of reasons, many of which are out of our control.

As at January 31, 2020 our current assets were $5,999 compared to $9,090 in current assets at January 31, 2019. As at January 31, 2020 our total assets were $6,277 compared to $9,600 in total assets at January 31, 2019. As at January 31, 2020, our current liabilities were $72,992, or an increase in the amount of $50,448 (or 223.78%) compared to $22,544 as of January 31, 2019. As of January 31, 2020, we had Loan from shareholders in the total amount of $60,432, or 82.79% of our total liabilities, as we have not been able to generate a steady cash flow to cover our operating expenses and have to rely heavily on the financial support from our shareholders.

Total Stockholders' deficit was $66,715 as of January 31, 2020, compared to $12,944 as of January 31, 2019, representing an increase in the amount of $53,771.

Cash Flows from Operating Activities

For the year ended January 31, 2020, net cash used by operating activities was $43,091, consisting of net loss of $53,771, depreciation expenses of $232, and an increase in accounts payable of $10,448.

For the year ended January 31, 2019, net cash used by operating activities was $45,354, consisting of net loss of $44,831, depreciation expenses of $464, and a decrease in accounts payable of $987.

Cash Flows from Investing Activities

Cash flows used in investing activities during years ended January 31, 2020 and 2019 were $0 and $0, respectively.

Cash Flows from Financing Activities

Cash flows provided by financing activities during the years ended January 31, 2020 and 2019 were $40,000 and $17,769, respectively. We were able to borrow an additional $20,000 loan from one of our major shareholders in April and May 2019 to pay operating expenses. In the month of August 2019, we were able to borrow a total of $10,000 from one of our major shareholders. In the month of September 2019, we were able to borrow a total of $10,000 from one of our major shareholders to pay operating expenses.

Cash flows provided by financing activities during year ended January 31, 2019 were $17,769, including repayment of loan from a former majority shareholder in the amount of $2,663 and proceeds from a current majority shareholder of $20,432.





                                   5  | Page

PLAN OF OPERATION AND FUNDING

We have no lines of credit or other bank financing arrangements. Currently we are financed by our major shareholders. Our working capital requirements for the next 12 months are expected to increase if and when we are able to execute on our current business plan. As of January 31, 2020, we had a working capital deficit in the amount of $66,993.

We also intend to finance our operating expenses and business development costs with further issuances of securities and debt issuances. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.





MATERIAL COMMITMENTS

As of the date of this Annual Report, we do not have any material commitments.

PURCHASE OF SIGNIFICANT EQUIPMENT

We do not intend to purchase any significant equipment during the next twelve months.

OFF-BALANCE SHEET ARRANGEMENTS

As of the date of this Annual Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.





RECENT DEVELOPMENTS

In December 2019, a strain of coronavirus entitled COVID-19 emerged in China and spread to other countries including to the United States. In March 2020, the World Health Organization declared COVID-19 to be a public health pandemic of international concern, which has resulted in travel restrictions and in some cases, prohibitions of non-essential activities, disruption and shutdown of businesses and greater uncertainty in global financial markets.

In the United States in which we and our customers, and partners operate, the health concerns as well as political or governmental developments in response to COVID-19 could result in economic, social or labor instability or prolonged contractions in certain end markets. These events could have a material adverse effect on the business and results of operations and financial condition.

At this time, it is difficult to predict the extent to which the COVID-19 outbreak will impact our business or operating results, which is highly dependent on uncertain future developments, including the severity of the pandemic and the actions taken or to be taken by governments and private businesses in relation to its containment. The Company's plan pf conducting new businesses might be delayed and the effect of the outbreak may not be fully reflected in our operating results until future periods.


                                   6  | Page

© Edgar Online, source Glimpses